Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kelly Shimabukuro
AIDS Associated Malignancies Clinical Trials Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Center for Clinical Aids Research and Education
Los Angeles, California, United States
- University of California San Diego
San Diego, California, United States
- San Francisco General Hospital
San Francisco, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Cancer Center of Hawaii-Hawaii Aids Clinical Research Program
Honolulu, Hawaii, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- Thomas Street Clinic
Houston, Texas, United States
- Harborview Medical Center
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2010
- Primary completion
- 4 Aug 2014
- Completion
- 4 Aug 2014
- Last update posted
- 8 Feb 2022
- Registered enrollment
- 38
- Registry id
- NCT01057121
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.